Press release
Osteoporosis Drugs Market to be Valued USD 20.17 Billion by 2026
According to TechSci Research report, “Global Osteoporosis Drugs Market By Drug Class (Bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors, and Others), By Osteoporosis Disease Type (Primary Osteoporosis, Secondary Osteoporosis), By Route of Administration (Oral, Injectable, and Others), By Gender (Female, Male), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Forecast & Opportunities, 2026”, the market is anticipated to grow at a healthy CAGR during the forecast period. The key factors propelling the growth of the global osteoporosis drugs market include rising prevalence of osteoporosis and surge in geriatric population around the world as they pose high susceptibility for osteoporosis. Growing adoption of sedentary lifestyle is also impacting bone health and thus, there is a rise in demand for osteoporosis drugs. Additionally, the increase in osteoporosis cases due to menopause in women is acting as a major growth driver for this market. In men, lifestyle associated factors such as smoking and alcohol abuse are found to promote osteoporosis. This is further expected to augment the global osteoporosis drugs market through 2026.
Moreover, increasing investment in R&D activities for the development of advanced new drug classes is also fueling the market growth. The wide range of pipeline drugs for approval in clinical trials are also expected to provide lucrative growth opportunities for osteoporosis drug manufacturers. However, the market is also prone to some challenges. Several side effects of osteoporosis drugs such as heartburn, nausea, irritable bowel syndrome and ulcers in the stomach are likely to hamper the market growth. Furthermore, the time-taking drug approval process is also anticipated to restrain the global osteoporosis drugs market growth.
Browse 182 Figures spread through 110 Pages and an in-depth TOC on "Global Osteoporosis Drugs Market"
https://www.techsciresearch.com/report/osteoporosis-drugs-market/5081.html
Global osteoporosis drugs market can be segmented based on disease type, drug class, route of administration, gender, distribution channel and region. Based on drug class, the market can be segmented into bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), parathyroid hormone therapy, calcitonin, rank ligand inhibitors, and others. Among them, parathyroid hormone therapy are expected to register highest CAGR during the forecast period as they are increasingly being used to treat osteoporosis and have lesser side effects.
Based on route of administration, global osteoporosis drugs market can be segmented into oral, injectable, and others. Among them, the oral segment accounted for largest market share in 2020 owing to abundant availability of medications which are taken orally. However, the injectable segment is anticipated to witness fastest growth through 2026 owing to growing need for drugs that exhibit improved bioavailability rapid mode of action.
Major companies operating in global osteoporosis drugs market include F. Hoffmann-La Roche Ltd, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Novartis International AG, GlaxoSmithKline Plc, Merck & Co. Inc., Amgen, Inc., Allergan plc, Eli Lilly and Company, Radius Health, Inc., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited, Sanofi S.A., Abiogen Pharma S.p.A., Merrion Pharmaceuticals Plc., among others. The companies are undergoing new product development and collaborative research initiatives to increase their share in global osteoporosis drugs market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5081
Customers can also request for 10% free customization on this report.
“North America dominated the global osteoporosis drugs market in 2020 and is expected to hold its dominance through 2026 owing to rising prevalence of osteoporosis and easy availability of osteoporosis drugs in the region. However, Asia Pacific is anticipated to undergo fastest growth during the forecast period due to thriving life science industry and growing awareness about the benefits of osteoporosis drugs,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Osteoporosis Drugs Market By Drug Class (Bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors, and Others), By Osteoporosis Disease Type (Primary Osteoporosis, Secondary Osteoporosis), By Route of Administration (Oral, Injectable, and Others), By Gender (Female, Male), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of global osteoporosis drugs market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global osteoporosis drugs market.
Browse Related Reports
Global Oral Drug Delivery Market By Formulation (Tablets, Capsules, Drops, Liquid or Syrup), By Type (Controlled Release, Orodispersible Tablets, Others), By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others), By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others), By Company, By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/oral-drug-delivery-market/7236.html
Global Regenerative Medicine Market By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Others), By Application (Musculoskeletal Disorders, Wound Care, Others), By Material (Synthetic Material, Biologically Derived Material, Others), By Cell (Autologous, Allogenic), By Product (Biologic, Cell -based Medical Devices, Others), By Technique (Microfracture, Mosaicplasty), By Distribution Channel (Hospitals, Clinics , Others), By Region & Opportunities, 2025
https://www.techsciresearch.com/report/regenerative-medicine-market/4685.html
About TechSci Research
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteoporosis Drugs Market to be Valued USD 20.17 Billion by 2026 here
News-ID: 2254847 • Views: …
More Releases from TechSci Research
India Dental Consumables Market: Analyzing the Key Segments and an 8.22% CAGR
The Foundation: Market Overview & Key Figures
Imagine a world where the simple act of a smile is a luxury, where toothaches are an accepted part of life. For many people in India, this has been the reality. But things are changing, and they're changing fast. The numbers tell a compelling story. According to a TechSci Research report, the India Dental Consumables Market was valued at a robust USD 234.65 million…
2030 Saudi Facility Management Market Outlook: Smart Cities Boost Demand
Market Outlook
The Saudi Arabia Facility Management Market was valued at USD 27.28 Billion in 2024 and is anticipated to reach USD 43.80 Billion by 2030, registering a strong CAGR of 8.05% during the forecast period. The market is driven by the country's growing investment in infrastructure, real estate development, and Vision 2030 initiatives aimed at diversifying the economy and enhancing public-private partnerships. The expansion of commercial and residential spaces, coupled…
Small Arms and Light Weapons Market to Grow at 6.59% CAGR Through 2029 - TechSci …
"Military modernization initiatives worldwide drive demand for advanced and modular SALW, emphasizing technological innovation are the factors driving Small Arms and Light Weapons market in the forecast period 2025-2029."
According to TechSci Research report, "Small Arms and Light Weapons Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029", The Global Small Arms and Light Weapons Market stood at USD 13.75 Billion in 2023 and is anticipated to grow…
Anticipating Growth: Luxury Sunglasses Market to Reach US$ 14.86 Billion with a …
TechSci Research's report on the "Global Luxury Sunglasses Market - Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029" reveals that the market reached USD 14.86 billion in 2023, projecting a 4.2% CAGR from 2025 to 2029. This market segment thrives within the broader eyewear industry, offering high-end, premium sunglasses to discerning consumers seeking exclusivity and sophistication. Driven by evolving fashion trends, increasing disposable incomes, and growing brand consciousness, the…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
